Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pristiq in elderly outpatients with MDD
NCT00242229Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2004
- Primary completion
- Oct 2005
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Oct 2004; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00242229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242229.